As shown in triple-negative patient-derived xenograft (PDX) models of breast cancer, pre-metastatic CCL2 niches are enriched in IFNγ-producing CCR2+ monocytes only in nonmetastatic areas. This evidence concerns the gene CCR2 and breast carcinoma.